BioNTech Valuation
| 22UA Stock | 113.80 2.90 2.61% |
At this time, the firm appears to be fairly valued. BioNTech SE shows a prevailing Real Value of USD115.16 per share. The current price of the firm is USD113.8. Our model approximates the value of BioNTech SE from analyzing the firm fundamentals such as Price To Sales of 2.44 X, current valuation of 29.68 B, and EBITDA of 15.13 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that BioNTech's price fluctuation is very steady at this time. Calculation of the real value of BioNTech SE is based on 3 months time horizon. Increasing BioNTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioNTech stock is determined by what a typical buyer is willing to pay for full or partial control of BioNTech SE. Since BioNTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioNTech Stock. However, BioNTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 113.8 | Real 115.16 | Hype 110.9 |
The real value of BioNTech Stock, also known as its intrinsic value, is the underlying worth of BioNTech SE Company, which is reflected in its stock price. It is based on BioNTech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioNTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioNTech SE helps investors to forecast how BioNTech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioNTech more accurately as focusing exclusively on BioNTech's fundamentals will not take into account other important factors: BioNTech Total Value Analysis
BioNTech SE is presently forecasted to have takeover price of 29.68 B with market capitalization of 29.68 B, debt of 171.6 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioNTech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.68 B | 29.68 B | 171.6 M |
BioNTech Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of BioNTech indicates not a very effective usage of assets in November.BioNTech Profitability Analysis
The company reported the revenue of 18.98 B. Net Income was 10.29 B with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BioNTech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BioNTech and how it compares across the competition.
About BioNTech Valuation
The stock valuation mechanism determines BioNTech's current worth on a weekly basis. Our valuation model uses a comparative analysis of BioNTech. We calculate exposure to BioNTech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioNTech's related companies.8 Steps to conduct BioNTech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioNTech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioNTech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioNTech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioNTech's revenue streams: Identify BioNTech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioNTech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioNTech's growth potential: Evaluate BioNTech's management, business model, and growth potential.
- Determine BioNTech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioNTech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |